Identifying barriers to translational research
Aft er receiving a CTSA award in 2007, the University of Michigan (U-M) conducted a strategic assessment of the translational research enterprise through over 100 extensive interviews of faculty and staff providing the infrastructure for translational research, as well as the investigators conducting that research. Th e institution then conducted a survey of research team members involved in human subject research to identify and describe the current challenges facing translational research-specifi cally, the administrative processes associated with its planning and execution. In addition to identifying the issues, the team rated the technical and cultural/political levels of diffi culty in implementing the solutions, as well as the corresponding impact each solution would potentially bring. Th ese were then graphically mapped on a three-dimensional bubble chart ( Figure 1 ). Th is stratifi cation assisted in the planning, design, and prioritization of solutions, off ering insights that guide the refi nement eff orts of a clinical research enterprise's organization, business, and information technology (IT) processes.
Recommended solutions being addressed by the CTSA Eight areas were identifi ed as solution categories. Th e topics include organizational, procedural, financial, structural, educational, technological, and cultural elements.
Transform and expedite study and contract approval process.
Th e contract approval process, especially in regard to industry protocols, was recognized by the faculty as their number one area of discontent. Th e approval process was not clear to research team members and varied widely by unit and department as well as by type of sponsor. Educational and process improvement opportunities were identified. To address these issues, U-M has set a goal to expedite study approval process so that the contract and regulatory processes are executed within 60 days from submission for all studies and 45 days for industry-sponsored studies . Th e primary strategy to accomplish this aggressive goal was to create a team consisting of members of the units involved and to reengineer processes and conduct a demonstration project for feasibility within 1 year. Secondary strategies included increasing the transparency of contracting within the system to allow better tracking of proposals by the faculty and study teams, publishing desirable contract terms on a website for faculty and staff to use as protocols are developed, and to create an interactive, web-based research road map to guide faculty and staff through the necessary administrative steps to conduct translational research. 
SCTS President's Message Updates
The University of Michigan School of Medicine Correspondence: KJ Pienta ( kpienta@umich.edu ) Th e primary strategy was to create a leveraging of the resources of the CTSA to develop a franchisable model built on best practice modules that could then be easily adopted by other units throughout the university. 3. Develop a customer friendly, transparent fi nancial system that spans clinical trial budget creation to account reconciliation and study close out. Th e lack of transparent and integrated fi nancial systems to track costs and other fi nancial aspects of clinical research including budgeting and billing remains a challenge for study team members. Th e University of Michigan Offi ce of Research has created the Calendar Review and Analysis Offi ce (CRAO) to assist researchers with this process and is currently implementing a clinical study budget tool, eTh ority, to create standard billing calenders and processes across the organization. CRAO will also champion the evaluation of fi nancial feasibility prior to proposal initiation; provide more assistance to PIs and research team members with study budgets, through increased training on best practices, budget negotiators, and standardized internal budget; and generate a new reconciliation report that will make study account statements more easily understood by research teams. Study coordinator turnover was noted to be 18% a year. Of all study coordinators, 75% have been at U-M less than 3 years, compared to 44% of the rest of U-M staff and 56% of study coordinators nationally. Study coordinators noted that there was no coherent program or "home" for them within the system. Several strategies have been developed and are being enacted to address this problem. Th e CTSA created a virtual, web-based site for study coordinator support that will eventually include standardized resources such as workfl ow steps, templates, forms, and answers to common questions. A monthly study coordinator forum has been enacted to share challenges and best practices. Human resources has been engaged to develop uniform study coordinator job descriptions and to mentor the coordinators to develop a meaningful career path.
Increase patient participation (enrollment) in research.
Th e institution has set an ambitious goal to double patient participation in research in 5 years, while decreasing the number of studies that do not enroll a subject to 5%. A primary strategy to accomplish this was the creation of a web-based participant registry (UMclinicalstudies.org) to help match interested patients and volunteers with open studies. Currently, over 7,000 participants are registered. U-M is also investing in an electronic medical record system that better enables queries and "fl ags" potentially eligible patients. Further investigation by a study team is necessary to determine the underlying reasons for poor accrual to studies, whether due to missed competitive enrollment periods, rare disease studies that inherently will be challenged to accrue, registry studies with open enrollment, lack of ability to fi nd enough patients within the patient population, or unwillingness to ask patients to participate. Understanding and addressing the underlying issues provides an opportunity for the CTSA to improve the quality, and potentially reduce "waste, " in the proposal and regulatory systems. 7. Achieve effi ciencies through integration of multiple, fragmented IT systems. More than 30 IT systems, as well as paper records, were identifi ed that are currently utilized by investigators to perform clinical and translational research. Moreover, multiple IT service providers exist across the institution with poorly defi ned roles, responsibilities, and accountability. Alignment of key IT systems and personnel that support clinical and translational research is imperative. Th e CTSA is playing a central role in developing and leading a cohesive strategy that integrates IT for researchers' benefi ts. For example, the institution is investing in a system-wide approach to develop an overall architecture that will create a clinical data repository. 8. Evolve the culture of U-M to be more supportive and enthusiastic of clinical research. Like many academic institutions, the University of Michigan has struggled to value clinical research References to the same extent as the basic sciences. In interviews and surveys, many faculty noted that choosing a career in clinical research can be seen as "falling between the cracks" or not as respected as a career in basic research. While improving infrastructure demonstrates value to these researchers, it is not enough. Th e CTSA has advocated to create a working group to make recommendations to University leadership to increase recognition for excellence in clinical research, to refi ne promotion and incentive criteria to value scholarly clinical activity and emphasize collaboration and innovation across all disciplines (team science). Furthermore, a plan is being developed to expand training programs to support training of those who want to become clinical and translational researchers, beyond the few slots that the CTSA (K and T programs) can currently support.
Conclusion
Th e mission of the CTSA to enhance an investigator's ability to conduct translational research at the University of Michigan has resulted in concrete organizational plans and investments to improve infrastructure of translational research and increase the satisfaction of participants, faculty, and staff who are engaged in these activities. 7 Similar changes are occurring at CTSA institutions all over the country, validating the vision of Dr. Zerhouni and the investment in these vehicles of change by the NIH.
